Cover Image
Market Research Report

Europe Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product, Application, End User

Published by The Insight Partners Product code 916889
Published Content info 163 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product, Application, End User
Published: October 31, 2019 Content info: 163 Pages
Description

The Europe oligonucleotide synthesis market is expected to reach US$ $ 1,270.95 Mn in 2027 from US$ 518.02 Mn in 2018. The market is estimated to grow with a CAGR of 13.7% from 2019-2027.

The growth of the oligonucleotide synthesis market is primarily attributed to the partnerships and collaborations undertaken by the market players as well as increasing venture capital investments in pharmaceutical and biotechnology companies. However, the growth of the market is restrained by factors such as frequently changing EU regulatory policies for biotechnology industry and European biotechnology sector lacks skilled professionals. On the other hand, new product development and rising investments by pharmaceutical and biotechnology companies is likely to have a positive impact on the growth of the Europe Oligonucleotide Synthesis market in the coming years.

There are various start-up companies that are providing the products/services for the biological processes. Synthetic biology has numerous applications in the chemical, agriculture, pharmaceutical and energy sectors. Companies such as, Ginkgo Bioworks works for the organism engineering, GenScript offers gene synthesis, Benchling which operates in CAD Tools, Transcriptis which is into bioinformatics operates for cloud labs/automation, Glowee offers consumer products, among the other companies operating in the synthetic biology.

Globally, the synthetic biology has set benchmark with its innovations and the dynamic results. Global leaders in biopharmaceutical industry are investing heavily in synthetic biology. For instance, synthetic DNA manufacturer DNA Script has announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures, with additional investment from Merck Ventures BV, the corporate venture arm of Merck KGaA, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest Partners.

Furthermore, in July 2018, Evonetix Awarded Innovate UK Funding for £1.3 million ($1.75M) Gene Synthesis Project. Innovate UK, the UK's innovation agency, will co-fund the £1.3 million project, which will be undertaken in collaboration with Durham University. Owing to the rising investment for the synthetic biology companies, the need and demand for the synthetic biology for the development of the new techniques may increase the market in the future years.

In 2018, the synthesized oligonucleotides segment held a largest market share of 48.2% of the oligonucleotide synthesis market, by product. This segment is also expected to dominate the market in 2027 owing to increasing use of the product in research and diagnostic purposes. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.

In 2018, the reagent segment held a largest market share of 45.2% of the oligonucleotide synthesis market, by application. This segment is also expected to dominate the market in 2027 owing to availability of funds as well as supportive government policies. The segment is also anticipated to witness the growth at a significant rate during the forecast period, 2018 to 2027.

In 2018, the academic research institutes segment held a largest market share of 45.3% of the oligonucleotide synthesis market, by end user. This segment is also expected to dominate the market in 2027. However, the diagnostic laboratories segment is anticipated to witness the fastest growth rate of 12% during the forecast period. This higher growth rate of the segment can be attributed to the efficiency of oligonucleotides for diagnostic process.

Some of the major primary and secondary sources for western blotting included in the report are, Ludwig-Maximilians-Universitat Munchen (LMU), Technical University Munich (TUM), Association For Responsible Research And Innovation In Genome Editing (ARRIGE), Biotechnology And Biological Sciences Research Council (BBSRC), Genetically Modified Crops And Organisms (GMOs), Cancer Genomics And Advanced Therapeutics (C-CAT) and others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe oligonucleotide synthesis market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Europe oligonucleotide synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table of Contents
Product Code: TIPRE00007128

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope Of The Study
  • 1.2 The Insight Partners Research Report Guidance

2. Europe Oligonucleotide Synthesis Market - Key Takeaways

3. Europe Oligonucleotide Synthesis Market - Market Landscape

  • 3.1 Overview
  • 3.2 Market Segmentation
    • 3.2.1 Europe Oligonucleotide Synthesis Market - By Product
    • 3.2.2 Europe Oligonucleotide Synthesis Market - By Application
    • 3.2.3 Europe Oligonucleotide Synthesis Market - By End User
    • 3.2.4 Europe Oligonucleotide Synthesis Market - By Country
  • 3.3 PEST Analysis
    • 3.3.1 Europe - PEST Analysis

4. Europe Oligonucleotide Synthesis Market-Key Market Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Heavy Investments by European Private Players in Synthetic Biology
    • 4.1.2 Synthesized Oligonucleotides to Treat Medical Conditions
    • 4.1.3 Rising Number of Research and Development Activities in Synthetic Biology
  • 4.2 Key Market Restraints
    • 4.2.1 Frequently Changing EU Regulatory Policies for Biotechnology Industry
    • 4.2.2 Biotechnology Sector Lacks Skilled Professionals
  • 4.3 Key Market Opportunities
    • 4.3.1 Collaborations - The Future of Innovation
  • 4.4 Future Trends
    • 4.4.1 New Product Developments in Synthetic Biology
  • 4.5 Impact Analysis

5. Oligonucleotide Synthesis - Europe Analysis

  • 5.1 Europe Oligonucleotide Synthesis Market Revenue Forecasts And Analysis
  • 5.2 Market Positioning
  • 5.3 Performance Of Key Players
    • 5.3.1 Thermo Fisher Scientific Inc.
    • 5.3.2 GenScript
  • 5.4 Expert Opinions

6. Europe Oligonucleotide Synthesis Market Analysis -By Product

  • 6.1 Overview
  • 6.2 Europe Oligonucleotide Synthesis Market, By Product, 2018 & 2027 (%)
  • 6.3 Synthesized Oligonucleotides Market
    • 6.3.1 Overview
    • 6.3.2 Europe Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
    • 6.3.3 Primers Market
      • 6.3.3.1 Overview
      • 6.3.3.2 Europe Primers Market Revenue and Forecasts to 2027 (US$ Mn)
    • 6.3.4 Probes Market
      • 6.3.4.1 Overview
        • 6.3.4.1.1 Europe Probes Market Revenue and Forecasts to 2027 (US$ Mn)
      • 6.3.4.2 Large-Scale Synthesis Oligonucleotides Market
        • 6.3.4.2.1 Overview
        • 6.3.4.2.2 Europe Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
      • 6.3.4.3 Others Market
        • 6.3.4.3.1 Overview
        • 6.3.4.3.2 Europe Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
  • 6.4 Reagents Market
    • 6.4.1 Overview
    • 6.4.2 Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
  • 6.5 Equipment Market
    • 6.5.1 Overview
    • 6.5.2 Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)

7. Europe Oligonucleotide Synthesis Market Analysis - By Application

  • 7.1 Overview
  • 7.2 Europe Oligonucleotide Synthesis Market, By Application, 2018 & 2027 (%)
  • 7.3 Research Market
    • 7.3.1 Overview
    • 7.3.2 Europe Research Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 Diagnostics Market
    • 7.4.1 Overview
    • 7.4.2 Europe Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.5 Therapeutics Market
    • 7.5.1 Overview
    • 7.5.2 Europe Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8. Europe Oligonucleotide Synthesis Market Analysis -By End User

  • 8.1 Overview
  • 8.2 Europe Oligonucleotide Synthesis Market, By End User, 2018 & 2027 (%)
  • 8.3 Academic Research Institutes Market
    • 8.3.1 Overview
    • 8.3.2 Europe Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Diagnostic Laboratories Market
    • 8.4.1 Overview
    • 8.4.2 Europe Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 Pharmaceutical & Biotechnology Companies Market
    • 8.5.1 Overview
    • 8.5.2 Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.6 Other End Users Market
    • 8.6.1 Overview
    • 8.6.2 Europe Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027

  • 9.1 Overview
    • 9.1.1 Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.2 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 9.1.2.1 Europe Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.1.3 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
    • 9.1.4 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.5 Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
    • 9.1.6 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.1 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.2 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 9.1.6.2.1 UK Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.6.3 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
      • 9.1.6.4 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.7 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.1 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.2 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 9.1.7.2.1 Germany Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.7.3 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
      • 9.1.7.4 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.8 France Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.1 France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.2 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 9.1.8.2.1 France Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.8.3 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
      • 9.1.8.4 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.9 Italy Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.9.1 Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.9.2 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 9.1.9.2.1 Italy Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.9.3 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
      • 9.1.9.4 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.10 Spain Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.10.1 Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.10.2 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 9.1.10.2.1 Spain Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.10.3 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
      • 9.1.10.4 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10. Oligonucleotide Synthesis Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Comparative Company Analysis
  • 10.3 Growth Strategies Done By The Companies In The Market, (%)
  • 10.4 Organic Developments
    • 10.4.1 Overview
  • 10.5 Inorganic Developments
    • 10.5.1 Overview

11. Oligonucleotide Synthesis Market-Key Company Profiles

  • 11.1 Thermo Fisher Scientific Inc.
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 GenScript
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Overview
    • 11.2.4 Product Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Synthomics, Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Ansa Biotechnologies, Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Iridia, Inc.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial overview
    • 11.5.4 Product Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Helixworks
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial overview
    • 11.6.4 Product Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Keasling Lab
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Molecular Assemblies
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Overview
    • 11.8.4 Product Portfolio
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Twist Bioscience
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Product portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Evonetix
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial overview
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Dna Script
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Financial overview
    • 11.11.4 Product Portfolio
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Nuclera Nucleics Ltd.
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Financial Overview
    • 11.12.4 Product Portfolio
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 Camena Bio
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Financial Overview
    • 11.13.4 Product Portfolio
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary Of Terms
  • 12.3 Methodology
    • 12.3.1 Coverage
    • 12.3.2 Secondary Research
    • 12.3.3 Primary Research

LIST OF TABLES

  • Table 1. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • Table 2. Europe Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 3. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • Table 4. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
  • Table 5. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • Table 6. UK Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 7. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • Table 8. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
  • Table 9. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • Table 10. Germany Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 11. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • Table 12. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
  • Table 13. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • Table 14. France Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 15. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • Table 16. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
  • Table 17. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • Table 18. Italy Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 19. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • Table 20. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
  • Table 21. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
  • Table 22. Spain Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
  • Table 23. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
  • Table 24. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
  • Table 25. Organic Developments Done By Companies
  • Table 26. Inorganic Developments Done By Companies
  • Table 27. Glossary Of Terms, Oligonucleotide Synthesis Market

LIST OF FIGURES

  • Figure 1. France Oligonucleotide Synthesis Market, Revenue (Us$ Bn), By 2018 & 2027
  • Figure 2. Europe Synthesized Oligonucleotides Market By Product, Market Share (%), 2018
  • Figure 3. Europe Oligonucleotide Synthesis Market By Application, Market Share (%), 2018
  • Figure 4. Europe Oligonucleotide Synthesis Market By End User, Market Share (%), 2018
  • Figure 5. Oligonucleotide Synthesis Market Segmentation
  • Figure 6. Europe PEST Analysis
  • Figure 7. Oligonucleotide Synthesis Market Impact Analysis Of Driver And Restraints
  • Figure 8. Europe Oligonucleotide Synthesis Market - Revenue Forecasts And Analysis - 2017- 2027
  • Figure 9. Europe Oligonucleotide Synthesis Market By Product, 2018 & 2027 (%)
  • Figure 10. Europe Synthesized Oligonucleotides Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 11. Europe Primers Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 12. Europe Probes Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 13. Europe Large-Scale Synthesis Oligonucleotides Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 14. Europe Others Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 15. Europe Reagents Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 16. Europe Equipment Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 17. Europe Oligonucleotide Synthesis Market By Application, 2018 & 2027 (%)
  • Figure 18. Europe Research Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 19. Europe Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 20. Europe Therapeutics Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 21. Europe Oligonucleotide Synthesis Market By End User, 2018 & 2027 (%)
  • Figure 22. Europe Academic Research Institutes Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 23. Europe Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 24. Europe Pharmaceutical & Biotechnology Companies Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 25. Europe Other End Users Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 26. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 27. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Country (%)
  • Figure 28. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 29. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 30. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 31. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 32. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
  • Figure 33. Comparative Company Analysis
  • Figure 34. Growth Strategies Done By The Companies In The Market, (%)
Back to Top